- Investing Ideas
- /
- Brazilian Potentially Undervalued Companies
Brazilian Potentially Undervalued Companies
UPDATED Mar 19, 2024
Companies with a Value score of at least 3, ordered by Value score
369 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
B1GN34 | US$35.37 | 0% | -24.0% | US$17.6b | US$56.51 | PS7.2x | E57.4% | n/a | Pharmaceuticals & Biotech | ||
HPQB34 | US$147.60 | -2.7% | -0.8% | US$29.2b | US$157.74 | PE8.5x | E-5.9% | 3.7% | Tech | ||
GMAT3 | R$8.36 | 1.3% | 53.4% | R$18.0b | R$9.01 | PE15.1x | E13.9% | n/a | Consumer Retailing | ||
RBED11 | R$145.00 | -1.3% | 17.6% | R$342.3m | n/a | PB1.1x | n/a | 11.3% | Real Estate | ||
DOTZ3 | R$6.02 | -4.7% | -29.2% | R$78.3m | R$30.00 | PE-0.9x | S21.5% | n/a | Media | ||
TEND3 | R$13.06 | 14.4% | 126.3% | R$1.5b | R$14.81 | PB1.9x | E78.3% | 0% | Consumer Durables | ||
G1DS34 | US$3.95 | -7.3% | -53.6% | US$1.5b | US$8.26 | PS1.1x | E26.1% | n/a | Software | ||
S1EA34 | US$158.15 | 0% | -43.5% | US$5.0b | US$197.00 | PE16.2x | E18.1% | 2.3% | Materials | ||
SOND3 | R$46.01 | 0% | n/a | R$106.9m | n/a | PE7.6x | n/a | 0% | Capital Goods | ||
J1EG34 | US$366.75 | 0% | n/a | US$18.6b | US$385.66 | PE26.4x | E16.6% | 0.8% | Commercial Services | ||
I1LM34 | US$127.01 | -7.4% | n/a | US$20.7b | US$152.35 | PS4.7x | E70.2% | n/a | Pharmaceuticals & Biotech | ||
A1LN34 | US$37.20 | 0% | -22.6% | US$18.6b | US$55.42 | PS10.2x | E60.8% | n/a | Pharmaceuticals & Biotech | ||
C1CI34 | US$131.17 | -4.0% | -22.2% | US$45.4b | US$145.99 | PB7.1x | E-1.7% | 6.0% | Real Estate | ||
CSRN3 | R$24.65 | -11.6% | -10.9% | R$4.1b | n/a | PE7.1x | n/a | 10.8% | Utilities | ||
S1LG34 | US$130.00 | 0.7% | 125.3% | US$3.6b | US$106.74 | PB0.9x | E76.3% | 5.8% | Real Estate | ||
REDE3 | R$6.84 | -2.3% | 35.2% | R$14.4b | n/a | PE8.7x | n/a | 8.4% | Utilities | ||
AMGN34 | US$48.57 | -1.7% | 12.0% | US$145.6b | US$54.36 | PE21.7x | E9.2% | 3.3% | Pharmaceuticals & Biotech | ||
S2GM34 | US$20.90 | -15.1% | n/a | US$1.4b | US$48.41 | PS14.5x | E-1.7% | n/a | Materials | ||
EVEN3 | R$8.15 | -5.5% | 71.9% | R$1.6b | R$8.56 | PE10x | E23.4% | 6.2% | Consumer Durables | ||
MTRE3 | R$4.75 | -18.1% | 38.5% | R$502.4m | R$7.83 | PE5.6x | E40.4% | 17.1% | Real Estate Management and Development | ||
REGN34 | US$80.40 | 1.1% | 21.1% | US$103.6b | US$84.87 | PE26.2x | E9.5% | n/a | Pharmaceuticals & Biotech | ||
AURE3 | R$11.91 | 0.7% | -17.7% | R$11.9b | R$14.99 | PS1.9x | E66.0% | 12.6% | Utilities | ||
W1HR34 | US$133.92 | -1.0% | -22.7% | US$5.8b | US$154.05 | PE12.2x | E17.5% | 6.5% | Consumer Durables | ||
N1CL34 | US$97.70 | -0.7% | 45.8% | US$8.3b | US$107.12 | PE49.8x | E46.7% | n/a | Consumer Services |